Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 55,233 shares at $54.13 ($3.0M) on 2009-12-22, disclosed to the SEC on 2009-12-23.
Scheduled sale ($3.0M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 220 | $0 | 0.0% |
| 2 | $54.10 | 16,380 | $886K | 29.8% |
| 3 | $54.10 | 36,449 | $2.0M | 66.3% |
| 4 | $54.11 | 200 | $11K | 0.4% |
| 5 | $54.12 | 684 | $37K | 1.2% |
| 6 | $54.13 | 1,300 |
| $70K |
| 2.4% |
| Total | $53.89 avg | 55,233 | $3.0M | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |